Disclosure Of Interests In Other Entities [Text Block]

Ascelia Pharma - Filing #678716

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Disclosure of interests in other entities [text block]	—	—	Not	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	Not	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	- SEK	—	—	—	—	—	—	—	—	- SEK	—	—	—	—	—
Current assets	—	—	—	28 937 SEK	—	—	—	—	160 869 SEK	—	—	—	—	—	—	—	—
Non-current assets	—	—	—	58 135 SEK	—	—	—	—	57 700 SEK	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	12 568 SEK	—	—	—	—	37 518 SEK	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	—	176,000 SEK	—	—	—	—	193,000 SEK	—	—	—	—	—	—	—	—
Revenue	—	—	- SEK	—	—	—	—	—	—	—	—	- SEK	—	—	—	—	—
Profit (loss)	- SEK	- SEK	109 288 SEK	—	- SEK	109 288 SEK	109 288 SEK	- SEK	—	- SEK	131 223 SEK	131 223 SEK	131 223 SEK	- SEK	- SEK	- SEK	—
Comprehensive income	- SEK	- SEK	109 589 SEK	—	- SEK	109 288 SEK	109 589 SEK	301,000 SEK	—	- SEK	130 504 SEK	130 504 SEK	131 223 SEK	- SEK	718,000 SEK	- SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	301,000 SEK	—	—	—	—	—	—	—	—	718,000 SEK	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	21 855 SEK	—	—	—	—	149 555 SEK	—	—	—	—	—	—	—	261 599 SEK
Tax expense (income)	—	—	319,000 SEK	—	—	—	—	—	—	—	—	1 933 SEK	—	—	—	—	—